Edition:
United States

Aduro Biotech Inc (ADRO.OQ)

ADRO.OQ on NASDAQ Stock Exchange Global Select Market

3.33USD
3:59pm EST
Change (% chg)

$0.13 (+4.06%)
Prev Close
$3.20
Open
$3.23
Day's High
$3.39
Day's Low
$3.21
Volume
100,917
Avg. Vol
110,678
52-wk High
$10.00
52-wk Low
$3.19

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.31 December 14 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.83 1.83 1.83 1.83

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 6 4.34 10.67 2.00 4.79
Quarter Ending Mar-19 3 4.93 6.60 3.80 4.75
Year Ending Dec-18 6 16.67 23.00 14.33 38.20
Year Ending Dec-19 6 26.23 55.00 5.23 58.38
Earnings (per share)
Quarter Ending Dec-18 5 -0.31 -0.26 -0.35 -0.23
Quarter Ending Mar-19 3 -0.31 -0.29 -0.34 -0.44
Year Ending Dec-18 5 -1.19 -1.14 -1.23 -1.45
Year Ending Dec-19 6 -1.20 -0.96 -1.37 -1.31

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 4.24 3.06 1.17 27.67
Quarter Ending Jun-18 4.26 2.64 1.62 38.03
Quarter Ending Mar-18 4.37 6.63 2.26 51.73
Quarter Ending Dec-17 4.21 3.76 0.46 10.82
Quarter Ending Sep-17 6.13 3.79 2.34 38.14

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 4.34 3.78 5.18 5.18 4.79
Quarter Ending Mar-19 4.93 4.93 5.60 5.10 4.75
Year Ending Dec-18 16.67 16.63 18.69 18.69 38.20
Year Ending Dec-19 26.23 26.23 29.47 35.72 58.38

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 2 0 2 3
Quarter Ending Mar-19 0 0 0 1
Year Ending Dec-18 1 1 1 5
Year Ending Dec-19 0 0 1 2
Earnings